径向体外冲击波治疗成人膝骨关节炎疼痛与功能的安慰剂对照随机临床试验方案
该方案为随机双盲对照试验,拟纳入30例膝骨关节炎受试者,随机接受径向体外冲击波或假径向体外冲击波治疗,每周1次共4周,所有受试者同时每周接受专业物理治疗。主要结局为疼痛视觉模拟评分,次要结局包括西安大略和麦克马斯特大学骨关节炎指数评分、膝关节活动度、10米步行测试及骨代谢生化指标,在基线、干预后5周和8周测量。
要点
- 30例膝骨关节炎受试者随机接受径向体外冲击波或假径向体外冲击波治疗,每周1次共4周。
- 主要结局为疼痛视觉模拟评分,次要结局包括西安大略和麦克马斯特大学骨关节炎指数评分、膝关节活动度、10米步行测试及骨代谢生化指标。
- 结局在基线、干预后5周和8周测量。
核心结论
- 该研究将探讨径向体外冲击波对膝骨关节炎受试者疼痛、身体功能和骨代谢生化指标的影响,预期可减轻受试者疼痛、改善功能并改善骨代谢生化指标。
- 所获信息将增进对径向体外冲击波治疗膝骨关节炎的理解,并可能用于标准化膝骨关节炎的临床治疗方案。
研究设计与样本
- 研究为随机双盲对照试验,纳入30例膝骨关节炎受试者。
- 受试者随机接受径向体外冲击波或假径向体外冲击波治疗患侧膝关节,每周1次共4周;治疗期间所有受试者每周接受1次专业物理治疗。
- 主要结局为疼痛视觉模拟评分;次要结局包括西安大略和麦克马斯特大学骨关节炎指数评分、膝关节活动度、10米步行测试结果及骨代谢生化指标。
- 结局在基线(T0)、干预后5周(T1)和干预后8周(T2)测量。
- 试验注册于中国临床试验注册中心,注册号ChiCTR2300069997,注册日期2023年3月30日。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knee osteoarthritis (KOA) is the most common degenerative joint disease. It is characterized by pain, stiffness, reduced joint motion, and muscle weakness. It also has the potential for long-term disability. Radial extracorporeal shock wave therapy (rESWT) is a noninvasive therapeutic modality widely used for the treatment of musculoskeletal disorders. However, the role of rESWT in the treatment of knee osteoarthritis remains controversial in previous clinical trials. This trial will investigate the efficacy of rESWT in improving the symptoms, function, and bone metabolic status of participants with knee osteoarthritis. METHODS: The study is a randomized, double-blind, controlled trial. Thirty participants with knee osteoarthritis will be randomized to receive either rESWT or sham rESWT on the affected knee once per week for 4 weeks. All participants will undergo professional physiotherapy once a week during the treatment period. The primary outcome is the visual analogue scale score for pain. Secondary outcomes include the Western Ontario and McMaster Universities Osteoarthritis Index score, knee range of motion, the 10-m walk test results, and bone metabolism biochemical indicators. Outcomes will be measured at baseline (T0), 5 weeks post-intervention (T1), and 8 weeks post-intervention (T2). DISCUSSION: This study will investigate the effects of rESWT on pain, physical function, and bone metabolism biochemical indicators in participants with knee osteoarthritis, which is expected to reduce the pain of participants, improve the function of participants, and improve bone metabolism biochemical indicators. The information obtained will enhance our understanding of rESWT for the treatment of knee osteoarthritis and may be used to standardize clinical treatment protocols for knee osteoarthritis. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2300069997. Registered on 30 March 2023.
引用
- Ren P, Wang Z, Liang Z, et al. Radial extracorporeal shock wave therapy for pain and function in adults with knee osteoarthritis: protocol for a placebo-controlled, randomized clinical trial. Trials. 2025. PMID: 40281559. doi:10.1186/s13063-025-08844-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。